Abstract
With great interest I read the article titled "Assessment of Acute Myocardial infarction by the use of special biochemical markers" by Rihab Akasha et al. The work done was commendable. Biochemical markers used as AMI diagnostic tests are often used in patients with acute chest pain. According to the World Health Organization, AMI diagnosis is based on at least 2 of the following three criteria: Chest pain, ECG changes, cardiac enzyme increase.
Keywords
Acute Myocardial infarction biochemical markers chest pain ECG changes cardiac enzyme increase
References
- Akasha R, Mohammed A, et al. Assessment of Acute Myocardial infarction by the use of special biochemical markers. Ulutas Med J. 2015; 1(3): 68-73
- Abramson JH. Risk markers for mortality among elderly men community study in Jerusalem, J. Chronic disease; 35: 563-572, 1982.
- Allain CC, et al. American Heart Association; Coronary Risk Handbook. Estimating Risk of Coronary Heart Disease in Daily practice. Clin Chem, 20: 470-475, 1974.
- Bakker AJ, Koelemay MW, Gorgels J. Failure of new biochemical markers to exclude acute MI at admission Lancer, 342, 1220-2, 1993.
Abstract
References
- Akasha R, Mohammed A, et al. Assessment of Acute Myocardial infarction by the use of special biochemical markers. Ulutas Med J. 2015; 1(3): 68-73
- Abramson JH. Risk markers for mortality among elderly men community study in Jerusalem, J. Chronic disease; 35: 563-572, 1982.
- Allain CC, et al. American Heart Association; Coronary Risk Handbook. Estimating Risk of Coronary Heart Disease in Daily practice. Clin Chem, 20: 470-475, 1974.
- Bakker AJ, Koelemay MW, Gorgels J. Failure of new biochemical markers to exclude acute MI at admission Lancer, 342, 1220-2, 1993.
Details
| Primary Language | English |
|---|---|
| Journal Section | Research Article |
| Authors | |
| Publication Date | April 1, 2017 |
| Published in Issue | Year 2017 |